non-small cell lung cancer
Conditions
Interventions
Treatment group:Chemotherapy and Heweiyangxue Granules
Control group:Chemotherapy and placebo granules
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? With clear histological or cytological pathology confirmed diagnosis of non-small cell lung cancer; ? Age =18 and <80 years old, regardless of gender; ?Eastern Cooperative Cancer Group (ECOG) physical status score 0-2, and expected survival =3 months; ? No serious organ function damage and meet the indications for chemotherapy; ? No mental abnormality or psychiatric disease; ? Patients understood the content of the study, voluntarily enrolled, and signed an informed consent form.
Exclusion criteria
Exclusion criteria: ?Have a clear history of allergy related to taking Chinese medicine; ? Those with severe, uncontrolled organic lesions or infections, such as decompensated cardiac, pulmonary, and renal failure, resulting in the inability to tolerate chemotherapy or those in poor general condition, unable to eat; ? Those who are unable to fill in the scale due to impaired consciousness or dyslexia; ? Participated in clinical trials of other drugs in the last 1 month or not yet finished.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MD Anderson Symptom Inventory-Traditional Chinese Medicine; | — |
Secondary
| Measure | Time frame |
|---|---|
| MASCC Antiemesis Tool;CRP;TNF-a;IL-6;IL-8;White blood cell;Red blood cell;Neutrophil;Hemoglobin;Platelet;Gastrin;Albumin;Prealbumin;Body Mass Index;Disease Control Rate; | — |
Countries
China
Contacts
Public ContactLing Xu
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed